<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110643/" ref="ordinalpos=2547&amp;ncbi_uid=3376170&amp;link_uid=PMC3110643" image-link="/pmc/articles/PMC3110643/figure/F5/" class="imagepopup">Fig 5. CsA increases TGFβ <span class="highlight" style="background-color:">pathway</span>-dependent <span class="highlight" style="background-color:">signaling</span> in xenograft human squamous tumors.  From: Cyclosporine A mediates Pathogenesis of Aggressive Cutaneous Squamous Cell Carcinoma by Augmenting Epithelial-Mesenchymal Transition: Role of TGF-? <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span>. </a></div><br /><div class="p4l_captionBody">(A) Immunofluorescence staining illustrates expression of TGFβ receptors and downstream signaling proteins Smads, Smad 2, 3, 4, and 7, in vehicle and CsA-treated tumors. (B) Western Blot analysis showing expression of TGFβ receptors and downstream signaling proteins Smads, Smad 2, 3, 4, and 7, in vehicle and CsA-treated tumors.</div></div>